Clinical Trials Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Virol. May 12, 2014; 3(2): 11-17
Published online May 12, 2014. doi: 10.5501/wjv.v3.i2.11
Figure 1
Figure 1 The Chemokine (C-C motif) ligand 20 production by HEC-1A cells exposed to seminal plasma specimens from human immunodeficiency virus-seronegative- or human immunodeficiency virus-seropositive+ subjects as expressed by comparison to untreated cells [Chemokine (C-C motif) ligand 20 index]. Interleukin-1 beta (IL-1β) was used as positive control. aP < 0.05. SP: Seminal plasma; HIV: Human immunodeficiency virus-seronegative.